We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+676.14%
AUM
$865B
AUM Growth
-$62.5B
Cap. Flow
-$15.6B
Cap. Flow %
-1.8%
Top 10 Hldgs %
34.38%
Holding
3,202
New
115
Increased
2,022
Reduced
804
Closed
71

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.82B
2
SE icon
Sea Limited
SE
+$1.38B
3
CSCO icon
Cisco
CSCO
+$1.16B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
IR icon
Ingersoll Rand
IR
+$1.03B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.54B
2
AMZN icon
Amazon
AMZN
+$1.75B
3
APH icon
Amphenol
APH
+$1.65B
4
KLAC icon
KLA
KLAC
+$1.5B
5
XEL icon
Xcel Energy
XEL
+$1.38B

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Financials 11.17%
3 Healthcare 11.1%
4 Communication Services 10.25%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXPE icon
2001
DXP Enterprises
DXPE
$2.49B
$1.31M ﹤0.01%
9,389
+1,652
+21% +$222K
UPBD icon
2002
Upbound Group
UPBD
$1.26B
$1.31M ﹤0.01%
72,561
+12,603
+21% +$246K
NEXT icon
2003
NextDecade
NEXT
$1.63B
$1.31M ﹤0.01%
170,729
+45,824
+37% +$261K
NUVB icon
2004
Nuvation Bio
NUVB
$2.33B
$1.3M ﹤0.01%
303,624
-2,404,929
-89% -$13.4M
HFWA icon
2005
Heritage Financial
HFWA
$1.22B
$1.3M ﹤0.01%
50,062
+6,814
+16% +$177K
EPC icon
2006
Edgewell Personal Care
EPC
$1.3B
$1.3M ﹤0.01%
60,940
+8,551
+16% +$172K
ATEC icon
2007
Alphatec Holdings
ATEC
$1.43B
$1.3M ﹤0.01%
119,471
+25,820
+28% +$376K
TWO
2008
Two Harbors Investment
TWO
$1.27B
$1.3M ﹤0.01%
113,706
+23,059
+25% +$258K
PRGS icon
2009
Progress Software
PRGS
$1.66B
$1.3M ﹤0.01%
50,574
-16,578
-25% -$634K
WEN icon
2010
Wendy's
WEN
$1.46B
$1.29M ﹤0.01%
185,797
+18,895
+11% +$145K
IMKTA icon
2011
Ingles Markets
IMKTA
$1.71B
$1.29M ﹤0.01%
14,343
+1,849
+15% +$150K
GIII icon
2012
G-III Apparel Group
GIII
$1.55B
$1.29M ﹤0.01%
46,518
+8,260
+22% +$242K
LEG icon
2013
Leggett & Platt
LEG
$1.47B
$1.29M ﹤0.01%
130,444
+19,656
+18% +$224K
TROX icon
2014
Tronox
TROX
$981M
$1.29M ﹤0.01%
131,782
+13,716
+12% +$95.1K
GLIBK
2015
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$929M
$1.29M ﹤0.01%
34,594
+5,858
+20% +$221K
IBCP icon
2016
Independent Bank Corp
IBCP
$797M
$1.28M ﹤0.01%
38,573
+4,534
+13% +$156K
DLX icon
2017
Deluxe
DLX
$1.25B
$1.28M ﹤0.01%
46,524
+7,218
+18% +$189K
AUPH icon
2018
Aurinia Pharmaceuticals
AUPH
$1.92B
$1.28M ﹤0.01%
86,222
+18,816
+28% +$275K
CNMD icon
2019
CONMED
CNMD
$1.33B
$1.28M ﹤0.01%
36,088
-122,640
-77% -$4.99M
TDOC icon
2020
Teladoc Health
TDOC
$1.69B
$1.28M ﹤0.01%
234,300
+29,395
+14% +$165K
TNK icon
2021
Teekay Tankers
TNK
$2.66B
$1.28M ﹤0.01%
17,400
+2,993
+21% +$200K
CECO icon
2022
Ceco Environmental
CECO
$3.94B
$1.27M ﹤0.01%
21,370
+3,983
+23% +$256K
MFA
2023
MFA Financial
MFA
$935M
$1.27M ﹤0.01%
132,951
+15,090
+13% +$149K
PUMP icon
2024
ProPetro Holding
PUMP
$1.31B
$1.27M ﹤0.01%
87,788
+23,702
+37% +$283K
FIGS icon
2025
FIGS
FIGS
$1.73B
$1.26M ﹤0.01%
85,631
+15,518
+22% +$199K

Similar funds

T. Rowe Price Associates's Q1 2026 Portfolio in Review

As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
  • T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
  • T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
  • T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
  • T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.